Literature DB >> 17041804

[Malign and refractory hypertension].

Georg Schaller1, Michael Wolzt.   

Abstract

Early occurences of organ damage, mainly in the cardiovascular system, the central nervous system, of the kidney or the retina, are hallmarks of a malign course in arterial hypertension. Peracute hypertensive emergencies can lead to a rapid deterioration of organ functions, a slower development is observed in patients with therapy-resistant forms of arterial hypertension. In the following article we discuss the historical trends in terminology and epidemiology, clinical symptoms, and possible causes for therapy-resistant hypertension. The latter mainly focuses on possible secondary forms of hypertension and on thoughts on therapy-resistance in primary, idiopathic arterial hypertension, as well as on possible therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17041804     DOI: 10.1007/s10354-006-0332-3

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  22 in total

Review 1.  The role of aldosterone antagonists in the management of resistant hypertension.

Authors:  Mari K Nishizaka; David A Calhoun
Journal:  Curr Hypertens Rep       Date:  2005-10       Impact factor: 5.369

2.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

3.  Salt sensitivity, anxiety, and irritability predict blood pressure increase over five years in healthy males.

Authors:  Hans-Christian Deter; Clemens Micus; Miriam Wagner; Arya M Sharma; Konrad Buchholz
Journal:  Clin Exp Hypertens       Date:  2006-01       Impact factor: 1.749

Review 4.  Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.

Authors:  Jeong-a Kim; Monica Montagnani; Kwang Kon Koh; Michael J Quon
Journal:  Circulation       Date:  2006-04-18       Impact factor: 29.690

Review 5.  Treatment of hypertension in the elderly.

Authors:  A F Lever; L E Ramsay
Journal:  J Hypertens       Date:  1995-06       Impact factor: 4.844

6.  2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

Authors: 
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

7.  Recovery in malignant hypertension presenting as acute renal failure.

Authors:  C G Isles; A McLay; J M Jones
Journal:  Q J Med       Date:  1984

8.  Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients.

Authors:  M E Thase
Journal:  J Clin Psychiatry       Date:  1998-10       Impact factor: 4.384

9.  Blood pressure screening, management and control in England: results from the health survey for England 1994.

Authors:  H M Colhoun; W Dong; N R Poulter
Journal:  J Hypertens       Date:  1998-06       Impact factor: 4.844

10.  Sympathetic neural mechanisms in obstructive sleep apnea.

Authors:  V K Somers; M E Dyken; M P Clary; F M Abboud
Journal:  J Clin Invest       Date:  1995-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.